STMN1 and breast cancer: Additionally, Carr et al. have reported that FOXM1 functioned chemoresistance to a microtubule stabilizing anticancer drug, paclitaxel by directly regulating the microtubule destabilizing protein Stathmin and altering dynamics of microtubule in breast cancer [25].